Loading...
A445680 logo

Curiox Biosystems Co., LtdKOSDAQ:A445680 Stock Report

Market Cap ₩1.1t
Share Price
₩69.70k
My Fair Value
n/a
1Y263.2%
7D-3.7%
Portfolio Value
View

Curiox Biosystems Co., Ltd

KOSDAQ:A445680 Stock Report

Market Cap: ₩1.1t

Curiox Biosystems (A445680) Stock Overview

Manufactures and sells medical appliances and instruments in South Korea. More details

A445680 fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health4/6
Dividends0/6

A445680 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Curiox Biosystems Co., Ltd Competitors

Price History & Performance

Summary of share price highs, lows and changes for Curiox Biosystems
Historical stock prices
Current Share Price₩69,700.00
52 Week High₩84,100.00
52 Week Low₩13,200.00
Beta4.91
1 Month Change3.57%
3 Month Change78.26%
1 Year Change263.21%
3 Year Changen/a
5 Year Changen/a
Change since IPO704.39%

Recent News & Updates

Is Curiox Biosystems (KOSDAQ:445680) Using Too Much Debt?

Oct 31
Is Curiox Biosystems (KOSDAQ:445680) Using Too Much Debt?

Does Curiox Biosystems (KOSDAQ:445680) Have A Healthy Balance Sheet?

Jul 16
Does Curiox Biosystems (KOSDAQ:445680) Have A Healthy Balance Sheet?

Recent updates

Is Curiox Biosystems (KOSDAQ:445680) Using Too Much Debt?

Oct 31
Is Curiox Biosystems (KOSDAQ:445680) Using Too Much Debt?

Does Curiox Biosystems (KOSDAQ:445680) Have A Healthy Balance Sheet?

Jul 16
Does Curiox Biosystems (KOSDAQ:445680) Have A Healthy Balance Sheet?

Curiox Biosystems (KOSDAQ:445680) Has Debt But No Earnings; Should You Worry?

Dec 16
Curiox Biosystems (KOSDAQ:445680) Has Debt But No Earnings; Should You Worry?

We're Not Very Worried About Curiox Biosystems' (KOSDAQ:445680) Cash Burn Rate

Jun 20
We're Not Very Worried About Curiox Biosystems' (KOSDAQ:445680) Cash Burn Rate

We're Interested To See How Curiox Biosystems (KOSDAQ:445680) Uses Its Cash Hoard To Grow

Mar 04
We're Interested To See How Curiox Biosystems (KOSDAQ:445680) Uses Its Cash Hoard To Grow

Shareholder Returns

A445680KR Life SciencesKR Market
7D-3.7%1.6%1.6%
1Y263.2%36.0%61.8%

Return vs Industry: A445680 exceeded the KR Life Sciences industry which returned 36% over the past year.

Return vs Market: A445680 exceeded the KR Market which returned 61.8% over the past year.

Price Volatility

Is A445680's price volatile compared to industry and market?
A445680 volatility
A445680 Average Weekly Movement13.8%
Life Sciences Industry Average Movement6.8%
Market Average Movement5.1%
10% most volatile stocks in KR Market10.8%
10% least volatile stocks in KR Market2.5%

Stable Share Price: A445680's share price has been volatile over the past 3 months compared to the KR market.

Volatility Over Time: A445680's weekly volatility (14%) has been stable over the past year, but is still higher than 75% of KR stocks.

About the Company

FoundedEmployeesCEOWebsite
201827Namyong Kimwww.curiox.com

Curiox Biosystems Co., Ltd manufactures and sells medical appliances and instruments in South Korea. It offers laminar wash HT2000, a laminar washing technology system that produces segregated data that enables high cell retention and viability, and laminar wash auto 1000, a system that automates the complete surface and intracellular staining workflow for flow and mass cytometry. The company also provides the laminar wash mini system, which offers a suspension-cell sample preparation method that eliminates the centrifuge; laminar wash plates, which eliminate centrifugation; Droparray instruments for multiplex immunoassays; and Droparray bead plates that reduce sample preparation and enhance data quality and biosafety.

Curiox Biosystems Co., Ltd Fundamentals Summary

How do Curiox Biosystems's earnings and revenue compare to its market cap?
A445680 fundamental statistics
Market cap₩1.13t
Earnings (TTM)-₩24.24b
Revenue (TTM)₩3.82b
311.4x
P/S Ratio
-49.1x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
A445680 income statement (TTM)
Revenue₩3.82b
Cost of Revenue₩2.38b
Gross Profit₩1.45b
Other Expenses₩25.68b
Earnings-₩24.24b

Last Reported Earnings

Jun 30, 2025

Next Earnings Date

n/a

Earnings per share (EPS)-1.42k
Gross Margin37.85%
Net Profit Margin-633.63%
Debt/Equity Ratio30.2%

How did A445680 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/11/17 08:45
End of Day Share Price 2025/11/17 00:00
Earnings2025/06/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Curiox Biosystems Co., Ltd is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.